Skip to content

Pharma Equity Group A/S Cl A Price, Chart & Factor Analysis

Free Data & Analytics Access
Pharma Equity Group A/S Cl A · E.PEG.CO · Denmark
Use symbol E.PEG.CO in our API & Excel add-in to retrieve this data ↓
0.07
(+0.04%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -50%
Trend -100%
Bubble Risk LOW
Realised Volatility (20D) 85.00%

Pharma Equity Group A/S Cl A Forecast

Pharma Equity Group A/S Cl A short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 85.0% a year, a typical one-standard-deviation range is 0.0658–0.0838 over a week, 0.0564–0.0932 over a month and 0.0112–0.1384 over a year. (Signals as of 21 Nov 2026.)

Pharma Equity Group A/S Cl A Price Chart

MacroFinance.ai

Pharma Equity Group A/S Cl A Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Pharma Equity Group A/S Cl A
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Pharma Equity Group A/S Cl A
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Pharma Equity Group A/S Cl A
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Pharma Equity Group A/S Cl A, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Pharma Equity Group A/S Cl A

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Pharma Equity Group A/S Cl A Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Pharma Equity Group A/S Cl A; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How Pharma Equity Group A/S Cl A’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Pharma Equity Group A/S Cl A behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Pharma Equity Group A/S Cl A (Denmark)

Pharma Equity Group A/S Cl A is a listed security in Denmark. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Petards Group plc

Frequently asked questions

What is Pharma Equity Group A/S Cl A?
Pharma Equity Group A/S Cl A is a listed security in Denmark. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Pharma Equity Group A/S Cl A price?
The latest close is 0.0748 (21 Nov 2026), +0.04% on the day. The price at the top of the page refreshes during the trading day.
Is Pharma Equity Group A/S Cl A in an uptrend?
As of 21 Nov 2026, short-term momentum is negative (1 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (0 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Pharma Equity Group A/S Cl A?
20-day realised volatility is 85.0% a year (21 Nov 2026), which implies a typical one-standard-deviation move of about 24.5% over a month and 12.0% over a week.
What factors affect Pharma Equity Group A/S Cl A?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Pharma Equity Group A/S Cl A, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Pharma Equity Group A/S Cl A?
9 backtested tactical asset allocation strategies trade Pharma Equity Group A/S Cl A through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Pharma Equity Group A/S Cl A returns analysed?
The Statistical Distribution of Returns section shows the distribution of Pharma Equity Group A/S Cl A daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Pharma Equity Group A/S Cl A historical data?
In the Free historical data section of this page: the last 10 years of Pharma Equity Group A/S Cl A daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Pharma Equity Group A/S Cl A historical data (last 10 years)

Browse or instantly download the last 10 years of Pharma Equity Group A/S Cl A daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.PEG.CO&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-200.0748
2026-11-190.0722
2026-11-180.0724
2026-11-170.0754
2026-11-160.076
2026-11-130.0726
2026-11-120.0726
2026-11-110.0798
2026-11-100.0796
2026-11-090.072
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which the current therapy is lacking or in need of improvement. Its products under development, includes RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouchitis; and RNX-051 for the treatment of colorectal cancer and colon adenoma that are in Phase II clinical trials. The company was incorporated in 2002 and is headquartered in Horsholm, Denmark.